GFC Life Science is a biotechnology-driven cosmetic materials company with distinguished R&D capabilities, particularly in the field of exosome-based ingredients. With a fully integrated one-stop production chain — from raw material development and mass production to finished product manufacturing — the company provides the GFCCELL exosome skin booster line optimized to meet global market and customer needs.

With over 130 patents and a research workforce comprising approximately 50% of its employees, GFC Life Science has established strong technological competitiveness. Following its KOSDAQ listing in 2025, the company has continued to validate its technological strength by supplying exosome-based raw materials to global cosmetic brands. Leveraging its worldwide distribution network, the company exports its skin booster products globally and leads the regenerative aesthetics market with diversified product portfolios for dermatology clinics, aesthetic centers, and homecare channels.